Literature DB >> 12665570

The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.

Gerda Lagger1, Angelika Doetzlhofer, Bernd Schuettengruber, Eva Haidweger, Elisabeth Simboeck, Julia Tischler, Susanna Chiocca, Guntram Suske, Hans Rotheneder, Erhard Wintersberger, Christian Seiser.   

Abstract

The cyclin-dependent kinase inhibitor p21/WAF1/CIP1 is an important regulator of cell cycle progression, senescence, and differentiation. Genotoxic stress leads to activation of the tumor suppressor p53 and subsequently to induction of p21 expression. Here we show that the tumor suppressor p53 cooperates with the transcription factor Sp1 in the activation of the p21 promoter, whereas histone deacetylase 1 (HDAC1) counteracts p53-induced transcription from the p21 gene. The p53 protein binds directly to the C terminus of Sp1, a domain which was previously shown to be required for the interaction with HDAC1. Induction of p53 in response to DNA-damaging agents resulted in the formation of p53-Sp1 complexes and simultaneous dissociation of HDAC1 from the C terminus of Sp1. Chromatin immunoprecipitation experiments demonstrated the association of HDAC1 with the p21 gene in proliferating cells. Genotoxic stress led to recruitment of p53, reduced binding of HDAC1, and hyperacetylation of core histones at the p21 promoter. Our findings show that the deacetylase HDAC1 acts as an antagonist of the tumor suppressor p53 in the regulation of the cyclin-dependent kinase inhibitor p21 and provide a basis for understanding the function of histone deacetylase inhibitors as antitumor drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665570      PMCID: PMC152549          DOI: 10.1128/MCB.23.8.2669-2679.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

1.  Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.

Authors:  J M Espinosa; B M Emerson
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

2.  Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.

Authors:  S Nakamura; J A Roth; T Mukhopadhyay
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.

Authors:  L Liu; D M Scolnick; R C Trievel; H B Zhang; R Marmorstein; T D Halazonetis; S L Berger
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  DNA damage activates p53 through a phosphorylation-acetylation cascade.

Authors:  K Sakaguchi; J E Herrera; S Saito; T Miki; M Bustin; A Vassilev; C W Anderson; E Appella
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

5.  Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C.

Authors:  J W Han; S H Ahn; Y K Kim; G U Bae; J W Yoon; S Hong; H Y Lee; Y W Lee; H W Lee
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

6.  Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line.

Authors:  A L Gartel; E Goufman; F Najmabadi; A L Tyner
Journal:  Oncogene       Date:  2000-10-26       Impact factor: 9.867

7.  Negative control of p53 by Sir2alpha promotes cell survival under stress.

Authors:  J Luo; A Y Nikolaev; S Imai; D Chen; F Su; A Shiloh; L Guarente; W Gu
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

8.  hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Authors:  H Vaziri; S K Dessain; E Ng Eaton; S I Imai; R A Frye; T K Pandita; L Guarente; R A Weinberg
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

9.  Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.

Authors:  J W Han; S H Ahn; S H Park; S Y Wang; G U Bae; D W Seo; H K Kwon; S Hong; H Y Lee; Y W Lee; H W Lee
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

10.  p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells.

Authors:  S Y Archer; S Meng; A Shei; R A Hodin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more
  85 in total

1.  Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.

Authors:  Wendell S Fortson; Shubhalaxmi Kayarthodi; Yasuo Fujimura; Huali Xu; Roland Matthews; William E Grizzle; Veena N Rao; Ganapathy K Bhat; E Shyam P Reddy
Journal:  Int J Oncol       Date:  2011-04-21       Impact factor: 5.650

Review 2.  Multiple roles of class I HDACs in proliferation, differentiation, and development.

Authors:  Nina Reichert; Mohamed-Amin Choukrallah; Patrick Matthias
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

3.  A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.

Authors:  Elisabeth Simboeck; Anna Sawicka; Gordin Zupkovitz; Silvia Senese; Stefan Winter; Franck Dequiedt; Egon Ogris; Luciano Di Croce; Susanna Chiocca; Christian Seiser
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

4.  mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival.

Authors:  Jan-Hermen Dannenberg; Gregory David; Sheng Zhong; Jaco van der Torre; Wing H Wong; Ronald A Depinho
Journal:  Genes Dev       Date:  2005-07-01       Impact factor: 11.361

5.  TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3.

Authors:  Arabinda Samanta; Bin Li; Xiaomin Song; Kathryn Bembas; Geng Zhang; Makoto Katsumata; Sandra J Saouaf; Qiang Wang; Wayne W Hancock; Yuan Shen; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

6.  Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression.

Authors:  Shih-Shin Chang; You-Chang Lo; Huey-Huey Chua; Hsin-Yi Chiu; Shu-Chun Tsai; Jen-Yang Chen; Kwok-Wai Lo; Ching-Hwa Tsai
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

7.  Inhibition of NF-kappaB activation by the histone deacetylase inhibitor 4-Me2N-BAVAH induces an early G1 cell cycle arrest in primary hepatocytes.

Authors:  P Papeleu; A Wullaert; G Elaut; T Henkens; M Vinken; G Laus; D Tourwé; R Beyaert; V Rogiers; T Vanhaecke
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

8.  Role for histone deacetylase 1 in human tumor cell proliferation.

Authors:  Silvia Senese; Katrin Zaragoza; Simone Minardi; Ivan Muradore; Simona Ronzoni; Alfonso Passafaro; Loris Bernard; Giulio F Draetta; Myriam Alcalay; Christian Seiser; Susanna Chiocca
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

9.  Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation.

Authors:  Axel Weber; Judith Marquardt; David Elzi; Nicole Forster; Sven Starke; Andre Glaum; Daisuke Yamada; Pierre-Antoine Defossez; Jeffrey Delrow; Robert N Eisenman; Holger Christiansen; Martin Eilers
Journal:  EMBO J       Date:  2008-05-01       Impact factor: 11.598

10.  Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).

Authors:  Ying Zhao; Shaoli Lu; Lipeng Wu; Guolin Chai; Haiying Wang; Yingqi Chen; Jia Sun; Yu Yu; Wen Zhou; Quanhui Zheng; Mian Wu; Gregory A Otterson; Wei-Guo Zhu
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.